A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)

Files in this item

10.1111_bjh.17420.pdf (446.7Kb)

Date

2021

Author

Rummel, Mathias J.

Janssens, Ann

MacDonald, David

Keating, Mary-Margaret

Zaucha, Jan M.

Davis, Jaclyn

Lasher, Janet

Babanrao Pisal, Chaitali

Izquierdo, Miguel

Friedberg, Jonathan W.

Metadata

Show full item record

BibTeX Export

Quotable link

http://dx.doi.org/10.22029/jlupub-9112

Original publication in

British journal of haematology 193 (2021), 1123-1133

URI of original publication

https://doi.org/10.1111/bjh.17420

Collections

• Publikationen im Open Access gefördert durch die UB